News Medical on MSN
In silico docking of clinically approved drugs against the SARS-CoV-2 receptor-binding domain
In this study in silico docking models were employed to investigate the molecular interactions between the receptor-binding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback